Advertisement

Lisa M. DeAngelis, MD, Named Physician-in-Chief and Chief Medical Officer of Memorial Sloan Kettering


Advertisement
Get Permission

Lisa M. DeAngelis, MD

Lisa M. DeAngelis, MD

The Memorial Sloan Kettering (MSK) Cancer Center recently announced that Lisa M. DeAngelis, MD, has been named Physician-in-Chief and Chief Medical Officer. An expert in brain cancer, Dr. DeAngelis previously served as Chair of the Department of Neurology and was Co-Founder of MSK’s Brain Tumor Center during her 30-plus years at the institution.

As Physician-in-Chief, Dr. DeAngelis will direct the entire clinical care enterprise and continuum of care at MSK, leading a staff of cancer experts that includes more than 1,200 hospital attendings and almost 4,000 registered nurses. She will be responsible for the management of all patient care services across the MSK system, including a 500-bed inpatient hospital, 13 outpatient facilities in New York City, and 7 regional care sites throughout New York and New Jersey. She will also focus on clinical strategic planning and will oversee MSK’s robust clinical and translational research programs.

Professional Experience and Research Focus

Dr. DeAngelis joined MSK as a neuro-oncology fellow in 1985, working with Jerome Posner, who was MSK’s founding Chair of Neurology. She became a critical member of MSK’s leadership team in 1997, when she was appointed Chair of the Department of Neurology, a position she held until assuming the Acting Physician-in-Chief role in September 2018. She co-founded MSK’s Brain Tumor Center.

Her research has focused on primary brain tumors and the neurologic complications of cancer and its treatment, such as cognitive impairment and strokes. She helped develop the current regimen to treat primary central nervous system lymphoma and has led numerous national clinical trials to investigate new brain tumor therapies.

Dr. DeAngelis is an elected member of the National Academy of Medicine and a Fellow of the American Academy of Neurology and the American Neurological Association. She also served previously on the Board of Directors for the Society for Neuro-Oncology. 


Advertisement

Advertisement



Advertisement